194 related articles for article (PubMed ID: 36189202)
1. Blau syndrome: Lessons learned in a tertiary care centre at Chandigarh, North India.
Kumrah R; Pilania RK; Menia NK; Rawat A; Sharma J; Gupta A; Vignesh P; Jindal AK; Rikhi R; Agarwal A; Gupta V; Singh S; Suri D
Front Immunol; 2022; 13():932919. PubMed ID: 36189202
[TBL] [Abstract][Full Text] [Related]
2. A novel mutation in early-onset sarcoidosis/Blau syndrome: an association with Propionibacterium acnes.
Okazaki F; Wakiguchi H; Korenaga Y; Nakamura T; Yasudo H; Uchi S; Yanai R; Asano N; Hoshii Y; Tanabe T; Izawa K; Honda Y; Nishikomori R; Uchida K; Eishi Y; Ohga S; Hasegawa S
Pediatr Rheumatol Online J; 2021 Feb; 19(1):18. PubMed ID: 33602264
[TBL] [Abstract][Full Text] [Related]
3. Case Report: Methotrexate and hydroxychloroquine in combination for the treatment of NOD2-mutation-associated Blau syndrome.
Jensen ME; Harrell K; McBride JD
Front Immunol; 2023; 14():1279329. PubMed ID: 37868966
[TBL] [Abstract][Full Text] [Related]
4. A Novel Pathogenic
Rodrigues FG; Petrushkin H; Webster AR; Bickerstaff M; Moraitis E; Rowczenio D; Aróstegui JI; Westcott M
Ophthalmic Genet; 2021 Dec; 42(6):753-764. PubMed ID: 34251956
[TBL] [Abstract][Full Text] [Related]
5. Familial Blau syndrome:First molecularly confirmed report from India.
Janarthanan M; Poddar C; Sudharshan S; Seabra L; Crow YJ
Indian J Ophthalmol; 2019 Jan; 67(1):165-167. PubMed ID: 30574935
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics and treatment of 50 cases of Blau syndrome in Japan confirmed by genetic analysis of the
Matsuda T; Kambe N; Ueki Y; Kanazawa N; Izawa K; Honda Y; Kawakami A; Takei S; Tonomura K; Inoue M; Kobayashi H; Okafuji I; Sakurai Y; Kato N; Maruyama Y; Inoue Y; Otsubo Y; Makino T; Okada S; Kobayashi I; Yashiro M; Ito S; Fujii H; Kondo Y; Okamoto N; Ito S; Iwata N; Kaneko U; Doi M; Hosokawa J; Ohara O; Saito MK; Nishikomori R; ;
Ann Rheum Dis; 2020 Nov; 79(11):1492-1499. PubMed ID: 32647028
[TBL] [Abstract][Full Text] [Related]
7. A young female with early onset arthritis, uveitis, hepatic, and renal granulomas: a clinical tryst with Blau syndrome over 20 years and case-based review.
Jindal AK; Pilania RK; Suri D; Gupta A; Gattorno M; Ceccherini I; Kumar N; Bansal R; Nada R; Singh S
Rheumatol Int; 2021 Jan; 41(1):173-181. PubMed ID: 31062074
[TBL] [Abstract][Full Text] [Related]
8. Optic nerve and retinal features in uveitis associated with juvenile systemic granulomatous disease (Blau syndrome).
Carreño E; Guly CM; Chilov M; Hinchcliffe A; Arostegui JI; Lee RW; Dick AD; Ramanan AV
Acta Ophthalmol; 2015 May; 93(3):253-7. PubMed ID: 25209167
[TBL] [Abstract][Full Text] [Related]
9. NOD2 gene-associated pediatric granulomatous arthritis: clinical diversity, novel and recurrent mutations, and evidence of clinical improvement with interleukin-1 blockade in a Spanish cohort.
Aróstegui JI; Arnal C; Merino R; Modesto C; Antonia Carballo M; Moreno P; García-Consuegra J; Naranjo A; Ramos E; de Paz P; Rius J; Plaza S; Yagüe J
Arthritis Rheum; 2007 Nov; 56(11):3805-13. PubMed ID: 17968944
[TBL] [Abstract][Full Text] [Related]
10. Blau syndrome with a rare mutation in exon 9 of
Velickovic J; Silan F; Bir FD; Silan C; Albuz B; Ozdemir O
Autoimmunity; 2019; 52(7-8):256-263. PubMed ID: 31556326
[TBL] [Abstract][Full Text] [Related]
11. Blau syndrome: cross-sectional data from a multicentre study of clinical, radiological and functional outcomes.
Rosé CD; Pans S; Casteels I; Anton J; Bader-Meunier B; Brissaud P; Cimaz R; Espada G; Fernandez-Martin J; Hachulla E; Harjacek M; Khubchandani R; Mackensen F; Merino R; Naranjo A; Oliveira-Knupp S; Pajot C; Russo R; Thomée C; Vastert S; Wulffraat N; Arostegui JI; Foley KP; Bertin J; Wouters CH
Rheumatology (Oxford); 2015 Jun; 54(6):1008-16. PubMed ID: 25416713
[TBL] [Abstract][Full Text] [Related]
12. Distinct NOD2 mutations reported in three families with Blau syndrome (BS) from a single center in India - Case series and review of literature.
Baisya R; Manthri R; Tyagi M; Uppin SG; Rajasekhar L
Clin Immunol; 2023 Oct; 255():109743. PubMed ID: 37604356
[TBL] [Abstract][Full Text] [Related]
13. Thalidomide may be an effective drug for Blau syndrome: a case report.
Wang W; Wang W; Zhong LQ; Li WD; Wu SJ; Song HM
Ann Palliat Med; 2022 Jul; 11(7):2538-2543. PubMed ID: 34775778
[TBL] [Abstract][Full Text] [Related]
14. Role of the NOD2 genotype in the clinical phenotype of Blau syndrome and early-onset sarcoidosis.
Okafuji I; Nishikomori R; Kanazawa N; Kambe N; Fujisawa A; Yamazaki S; Saito M; Yoshioka T; Kawai T; Sakai H; Tanizaki H; Heike T; Miyachi Y; Nakahata T
Arthritis Rheum; 2009 Jan; 60(1):242-50. PubMed ID: 19116920
[TBL] [Abstract][Full Text] [Related]
15. Blau Syndrome With Delayed Cutaneous Manifestations: A Case Report.
Panah E; Garfield E; Zahirsha Z; Muhlbauer A; Lake E; Speiser J
Am J Dermatopathol; 2024 Jun; 46(6):381-382. PubMed ID: 38648024
[TBL] [Abstract][Full Text] [Related]
16. A Novel NOD2-associated Mutation and Variant Blau Syndrome: Phenotype and Molecular Analysis.
Ebrahimiadib N; Samra KA; Domina AM; Stiles ER; Ewer R; Bocian CP; Foster CS
Ocul Immunol Inflamm; 2018; 26(1):57-64. PubMed ID: 27419275
[TBL] [Abstract][Full Text] [Related]
17. [Mutations of NOD2 gene and clinical features in Chinese Blau syndrome patients].
Wang W; Wei M; Song H; Qiu Z
Zhonghua Er Ke Za Zhi; 2014 Dec; 52(12):896-901. PubMed ID: 25619344
[TBL] [Abstract][Full Text] [Related]
18. Two Chinese pedigrees of Blau syndrome with thirteen affected members.
Wu D; Shen M
Clin Rheumatol; 2018 Jan; 37(1):265-270. PubMed ID: 28721627
[TBL] [Abstract][Full Text] [Related]
19. Blau syndrome with pulmonary nodule in a child.
Su J; Liu D
Australas J Dermatol; 2021 May; 62(2):217-220. PubMed ID: 33742458
[TBL] [Abstract][Full Text] [Related]
20. A Novel Mutation in Helical Domain 2 of NOD2 in Sporadic Blau Syndrome.
Jain L; Gupta N; Reddy MM; Mittal R; Barik MR; Panigrahi B; Monie T; Basu S
Ocul Immunol Inflamm; 2018; 26(2):292-294. PubMed ID: 27625029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
